Cg Oncology Inc (CGON)

R&D to Revenue

2887.15%

Fiscal year · Period ending:

CGON logo

CGON R&D to Revenue

Latest reported2887.15%
CGON FY R&D/Revenue (176.86% → 2887.15%)
High-resolution chart · PNG

CGON r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Cg Oncology Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
2,887.1535%
7,208.2529%
22,427.451%
15,198.4293%
176.8585%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.